![The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer]()
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancerRebello, R. J.; Kusnadi, E.; Cameron, D. P.; Pearson, H. B.; Lesmana, A.; Devlin, J. R.; Drygin, D.; Clark, A. K.; Porter, L.; Pedersen, J.; Sandhu, S.; Risbridger, G. P.; Pearson, R. B.; Hannan, R. D.; Furic, L. · Clinical Cancer Research · 2016